|
WO2021034925A1
|
|
Fixed-shape tissue matrix and related methods
|
|
US2021052775A1
|
|
Method of manufacturing particulate tissue products
|
|
WO2021003321A1
|
|
Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
|
|
WO2020247822A1
|
|
Coated polymeric material
|
|
US2020384156A1
|
|
Injectable mesh
|
|
WO2020243497A1
|
|
Biologic breast implant
|
|
WO2020227095A1
|
|
Breast treatment device
|
|
US2020315776A1
|
|
Composite tissue product anchor bolster for three-dimensional biologic scaffolds and related methods
|
|
WO2020163471A1
|
|
Meshed dermal tissue matrix products
|
|
WO2020150588A1
|
|
Time-delayed cross-linking of tissue fillers and applications thereof
|
|
US2020114091A1
|
|
Methods for introduction of flowable acellular tissue matrix products into a hand
|
|
WO2020123622A1
|
|
Devices, systems, and methods for tissue processing
|
|
WO2020117751A1
|
|
Devices and methods for treating tissues, including irradiated tissues
|
|
WO2020077087A1
|
|
Decellularized muscle matrix
|
|
US2020000855A1
|
|
Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
|
|
CA3089328A1
|
|
Tissue products with active agents and methods of production
|
|
US2019185814A1
|
|
Device and methods for tissue processing
|
|
WO2019084396A1
|
|
Small volume tissue processing devices
|
|
WO2019079672A1
|
|
Flowable acellular tissue matrix products and methods of production
|
|
EP3697337A1
|
|
Tissue products with variations in mechanical properties and methods of treatment
|
